United States HR 4390: PROTECT 340B Act of 2021
Status: Referred to the Subcommittee on Health. (as of 2021-07-12)
State: United States · Session: 117 · Bill: HR 4390
Sponsors: David B. McKinley, ADAM B. SCHIFF, ADAM SMITH, Abigail Davis Spanberger, Al Lawson, Alma S. Adams, Andy Kim, Ann Kirkpatrick, Ann M. Kuster, Austin Scott, Ayanna Pressley, BARBARA LEE, BOBBY L. RUSH, Ben Cline, Bill Foster, Brian K. Fitzpatrick, Bruce Westerman, C. A. Dutch Ruppersberger, Chellie Pingree, Chris Pappas, Colin Z. Allred, Cynthia Axne, DIANA DEGETTE, Daniel T. Kildee, Darren Soto
Bill Text
I 117TH CONGRESS 1ST SESSION H. R. 4390 To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes. IN THE HOUSE OF REPRESENTATIVES JULY 9, 2021 Mr. MCKINLEY (for himself and Ms. SPANBERGER) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be sub- sequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount pro- gram, and for other purposes. Be it enacted by the Senate and House of Representa-1 tives of the United States of America in Congress assembled, 2 SECTION 1. SHORT TITLE. 3 This Act may be cited as the ‘‘Preserving Rules Or-4 dered for The Entities Covered Through 340B Act of 5 2021’’ or the ‘‘PROTECT 340B Act of 2021’’. 6 VerDate Sep 11 2014 05:49 Jul 24, 2021 Jkt 019200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H4390.IH H4390SSpencer on DSK126QN23PROD with BILLS 2 •HR 4390 IH SEC. 2. FINDINGS AND PURPOSE. 1 (a) FINDINGS.—Congress finds the following: 2 (1) The 340B drug pricing program is an es-3 sential part of the Nation’s health care safety net. 4 (2) 340B enables safety-net providers to stretch 5 scarce resources further to offer services and treat 6 patients through the savings these providers receive 7 under the program. 8 (3) 340B savings support hospitals, clinics, and 9 health centers’ care for patients who have low in-10 comes, including those with low incomes enrolled in 11 Medicare and Medicaid. 12 (4) 340B savings are critically important to 13 rural hospitals that operate on very slim margins 14 and serve patients in isolated areas with limited ac-15 cess to health care. 16 (5) 340B supports care for those in need with-17 out using taxpayer dollars. 18 (6) Some commercial payers and pharmacy ben-19 efit managers are paying less to 340B covered enti-20 ties and their contract pharmacies for 340B drugs, 21 requiring identification of 340B drug claims or oth-22 erwise discriminating against 340B covered entities 23 and their contract pharmacies on the basis of their 24 status as providers or pharmacies that dispense 25 340B drugs. 26 VerDate Sep 11 2014 05:49 Jul 24, 2021 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H4390.IH H4390SSpencer on DSK126QN23PROD with BILLS 3 •HR 4390 IH (7) These types of discriminatory actions un-1 dermine the purpose of the 340B program and harm 2 the patients served by 340B covered entities. Com-3 mercial payers and pharmacy benefit managers’ im-4 position of requirements on a 340B pharmacy be-5 cause it is a pharmacy that dispenses 340B drugs, 6 or requirements with respect to the use of and bill-7 ing for drugs purchased under 340B because they 8 are 340B drugs is inconsistent with public policy be-9 cause of the deleterious effects on the nation’s 10 health care safety net. 11 (b) PURPOSES.—The purposes of this Act are the fol-12 lowing: 13 (1) To prohibit discriminatory actions, includ-14 ing several specified actions, by a pharmacy benefit 15 manager, a group health plan, a health insurance 16 issuer offering group or individual health insurance, 17 or a sponsor of a Medicare part D prescription drug 18 plan against 340B covered entities and their phar-19 macies and requiring them to be treated as any 20 other provider or pharmacy. 21 (2) To provide for the imposition of civil mone-22 tary penalties on pharmacy benefit managers that 23 violate the new protections and require the Health 24 VerDate Sep 11 2014 05:49 Jul 24, 2021 Jkt 019200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H4390.IH H4390SSpencer on DSK126QN23PROD with BILLS 4 •HR 4390 IH Services and Resources Administration to promul-1 gate implementing regulations. 2 (3) To authorize the Secretary to contract with 3 a third-party entity to collect and review data from 4 State Medicaid agencies and covered entities to pre-5 vent Medicaid duplicate discounts. 6 SEC. 3. ENSURING THE EQUITABLE TREATMENT OF COV-7 ERED ENTITIES AND PHARMACIES PARTICI-8 PATING IN THE 340B DRUG DISCOUNT PRO-9 GRAM. 10 (a) GROUP HEALTH PLAN AND HEALTH INSURANCE 11 ISSUER REQUIREMENTS.—Subpart II of part A of title 12 XXVII of the Public Health Service Act (42 U.S.C. 13 300gg–11 et seq.) is amended by adding at the end the 14 following new section: 15 ‘‘SEC. 2730. REQUIREMENTS RELATING TO THE 340B DRUG 16 DISCOUNT PROGRAM. 17 ‘‘(a) IN GENERAL.—A group health plan, a health 18 insurance issuer offering group or individual health insur-19 ance coverage, or a pharmacy benefit manager may not 20 discriminate against a covered entity (as defined in sub-21 section (d)(1)) or a specified pharmacy (as defined i
View United States HR 4390 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.